Oil Spill Dispersant Effectiveness Protocol. I: Impact of Operational Variables

The current U.S. Environmental Protection Agency protocol for testing the effectiveness of dispersants, the swirling flask test, has been found to give widely varying results in the hands of different testing laboratories. The sources of the ambiguities in the test were determined by considering several options in a rigorous systematic fashion. Options considered were variability among three operators and the variability and limitations of three analytical instruments in establishing a calibration curve for oil/dispersant mixtures. Other options included flask type, impact of operational variables (rotational speed, mixing time, settling time, and oil:dispersant ratio), development of a revised procedure for dispersant effectiveness, reproducibility and repeatability of the revised procedure, and development of selection criteria for screening of dispersants. A redesign of the test flask, which is characterized by having baffles with a stopcock at the bottom for sample collection, was deemed necessary to accomplish reproducibility within operator and between operators. The results indicated that the baffled flask provided a total coefficient of variation (variations within operator and between operators) less than 11% compared to above 100% in some cases for the swirling flask.     

Oil Spill Dispersant Effectiveness Protocol. II: Performance of Revised Protocol

The current U.S. Environmental Protection Agency (EPA) protocol for testing the effectiveness of dispersants for use in treating oil spills on the open water, the swirling flask test (SFT), has been found to give widely varying results in the hands of different testing laboratories. Part I addressed the sources of the ambiguities in the EPA SFT and the development of a new test referred to as the baffled flask test (BFT). In this part of the series, further experiments were conducted for estimating the repeatability of three operators in determining the effectiveness of 18 dispersants by both the EPA SFT and the BFT methods. Overall statistical analysis of the results indicated that the coefficient of variation by the BFT was only 7.8% compared to 21.9% for the EPA SFT. The mean percent effectiveness of the EPA SFT was only 19.7% as compared to 64.6% for the BFT. Proposed selection criteria for screening of dispersants for listing on the National Contingency Plan Product Schedule have been developed.     

Study of the Ghrelin/LEAP-2 Ratio in Humans and Rats during Different Phases of Pregnancy

The Liver-Expressed Antimicrobial Peptide 2 (LEAP-2) has emerged as an endogenous GHS-R antagonist and blunts the orexigenic action of ghrelin. This study aimed to determine the Ghrelin/LEAP-2 ratio in humans and rats during pregnancy. In humans, we conducted a nested case-control study within an observational prospective cohort. Healthy and mild preeclamptic pregnant women were studied at each trimester of gestation and three months postpartum. In addition, a group of non-pregnant women was studied into the follicular and luteal phases of the menstrual cycle. Furthermore, Ghrelin/LEAP-2 ratio was investigated in non-pregnant rats and at different periods of rat pregnancy. Human and rat serum ghrelin and LEAP-2 levels were determined using the commercially available ELISA kits. The Ghrelin/LEAP-2 ratio peak around the second trimester of gestation in healthy pregnant women (p < 0.05). Additionally, there were no statistically significant differences in Ghrelin/LEAP-2 ratio between healthy and preeclamptic pregnant women at each trimester of gestation (p > 0.05). The Ghrelin/LEAP-2 ratio in pregnant rat reached the peak around mid-gestation with a similar pattern to the human pregnancy. LEAP-2 was visualized by immunohistochemistry in human term placenta and rat placentas on days 12, 16 and 21 of pregnancy. In conclusion, this study provides the first evidence of a Ghrelin/LEAP-2 ratio peak around the half-way point of pregnancy onwards during human and rat pregnancy, and it might be associated with increased rates of weight gain during pregnancy. Thus, this study suggests that LEAP-2 and Ghrelin/LEAP-2 ratio might play an important role in maternal physiology adaptation of weight gain during pregnancy.     

Isomorphic Implication

We study the isomorphic implication problem for Boolean constraints. We show that this is a natural analog of the subgraph isomorphism problem. We prove that, depending on the set of constraints, this problem is in P, or is NP-complete, or is NP-hard, coNP-hard, and in P_‖^NP. We show how to extend the NP-hardness and coNP-hardness to P_‖^NP-hardness for some cases, and conjecture that this can be done in all cases. Supported in part by grants NSF-CCR-0311021 and DFG VO 630/5-1 and VO 630/5-2. An extended abstract of this paper appears in Proceedings of the 30th International Symposium on Mathematical Foundations of Computer Science (MFCS 2005), pp. 119–130, Springer-Verlag Lecture Notes in Computer Science #3618, August 2005. Work of M. Bauland done in part while visiting CASCI’s Laboratory for Complexity at Rochester Institute of Technology. Work of E. Hemaspaandra done in part while on sabbatical at the University of Rochester.     

A non-conserved sequence in the 5'region of the CYH2 intron from Saccharomyces cerevisiae controls splicing efficiency of the pre-mRNA

The CYH2 gene from Saccharomyces cerevisiae containing one 510 bp intron is spliced inefficiently. We have shown previously that a non-conserved sequence within the intron is responsible for this low splicing efficiency. Using synthetic oligonucleotides comprising the identified region we show in this report that a very short region contains the specificity to act negatively on the splicing efficiency of the CYH2 gene. Furthermore, this sequence influences the splicing efficiency only when it is placed close to the 5' splice site of the gene. Investigations with chimeric CYH2/beta-actin genes show that this sequence acts independent from its natural surroundings. We propose that this sequence might interact with splicing factor(s).     

Antimicrobial Activity and Hydrophobicity of Edible Whey Protein Isolate Films Formulated with Nisin and/or Glucose Oxidase

The use of edible antimicrobial films has been reported as a means to improve food shelf life through gradual releasing of antimicrobial compounds on the food surface. This work reports the study on the incorporation of 2 antimicrobial agents, nisin (N), and/or glucose oxidase (GO), into the matrix of Whey protein isolate (WPI) films at pH 5.5 and 8.5. The antimicrobial activity of the edible films was evaluated against Listeria innocua (ATCC 33090), Brochothrix thermosphacta (NCIB10018), Escherichia coli (JMP101), and Enterococcus faecalis (MXVK22). In addition, the antimicrobial activity was related to the hydrophobicity and water solubility of the WPI films. The greatest antibacterial activity was observed in WPI films containing only GO. The combined addition of N and GO resulted in films with lower antimicrobial activity than films with N or GO alone. In most cases, a pH effect was observed as greater antimicrobial response at pH 5.5 as well as higher film matrix hydrophobicity. WPI films supplemented with GO can be used in coating systems suitable for food preservation.     

Liquefaction of coal using supercritical fluid mixtures

Powhatan No. 5 and Bruceton coals were liquefied for 15–60 min at 653 K and 30 MPa in supercritical aqueous mixtures containing 10–20 wt% tetrahydroquinoline (THQ), quinoline or tetralin. The THQ-water mixtures produced the highest conversion to tetrahydrofuran (THF) soluble products (up to 74%). Tetralin-water, quinoline-water and pure water solvents gave increasingly lower yields of THF solubles. Addition of hydrogen to the quinoline-water solvent mixture increased yields slightly, but not to the level obtained using the THQ-water mixture.The yields of THF solubles in all instances depended upon the concentration of solvent in the mixture, with the 10 wt% THQ and 10 wt% tetralin (in water) giving higher yields than either 0 or 20 wt% concentrations. The nitrogen-containing solvents were chemically bonded to the THF-soluble product, as observed by g.p.c.     

A new enzymatically produced 1-lactulose: A pilot study to test the bifidogenic effects

In a novel pilot plant scale process, lactulose was synthesized enzymatically, operating a maximum batch volume of 170 L. The test product was subjected to a randomized, double-blind, placebo-controlled pilot feeding study. Participants consumed a milk serum drink for 14 days, equalling a daily intake of about 3 g d⁻¹ galactosyl-fructoses. Additionally, the effect of industrially produced lactulose and a placebo drink without lactulose was determined. So far, clinical studies on the prebiotic action of lactulose only focussed on the effects of industrially generated lactulose. The intake of enzymatically synthesized lactulose significantly increased (p = 0.001) faecal bifidobacterial counts, while there was no difference with industrially produced lactulose. Analysis of the compounds showed that the drink with enzymatically synthesized lactulose contained an additional disaccharide, β-1,1-galactosyl-fructose. Presumably, this sugar has a bifidogenic effect and may represent a novel prebiotic.     

Influence of Process Parameters on the Morphology of Spray‐Dried BaCl2 Powders

Spray‐drying is an effective method for producing powder aggregates with controlled size and morphology. Here, we report on a systematic study aimed at determining how spray‐drying parameters such as nozzle temperature, gas flow, salt concentration and solution feed rate, influence the characteristics of BaCl₂ granules prepared from aqueous solutions. We correlate the granule characteristics to these conditions through the use of processing maps and modeling. It is found that well‐dispersed, high density and spherical aggregates, which are favorable for subsequent powder compaction and sintering, can be obtained within a limited range of processing conditions.